Shilpa Medicare Ltd (SHILPAMED) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 780523, "name": "Shilpa Medicare", "stock_name": "Shilpa Medicare", "full_name": "Shilpa Medicare Ltd", "name_url": "stocks-analysis/shilpa-medicare", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "312.90", "chg": -20.25, "chgp": "-6.08%", "dir": -1, "prev_price": "333.15", "mcapval": "6,386.00 Cr", "mcap": "Small Cap", "scripcode": 530549, "symbol": "SHILPAMED", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE790G01031", "curr_date": "Mar 13", "curr_time": "", "bse_nse_vol": "3.87 lacs", "exc_status": "Active", "traded_date": "Mar 13, 2026", "traded_date_str": "2026 03 13", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shilpa-medicare-780523-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Shilpa Medicare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-sell-3884862", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShilpaMedicareL_mojoScore_3884862.png", "date": "2026-03-11 10:10:33", "description": "Shilpa Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 February 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 11 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Shilpa Medicare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-sell-3862109", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_mojoScore_3862109.png", "date": "2026-02-28 10:10:14", "description": "Shilpa Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Shilpa Medicare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-sell-3844157", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_mojoScore_3844157.png", "date": "2026-02-17 10:10:38", "description": "Shilpa Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 February 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Shilpa Medicare Gains 3.74%: 5 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-gains-374-5-key-factors-driving-the-weeks-volatility-3839738", "imagepath": "", "date": "2026-02-14 15:03:20", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Feb 09:</strong> Intraday high surge to Rs.359.95 with a 14.47% gap up</p>\n <p><strong>Feb 09:</strong> Very positive quarterly financial results reported</p>\n <p><strong>Feb 11-12:</strong> Consecutive declines amid technical caution</p>\n <p><strong>Feb 13:</strong> Modest recovery to close the week at Rs.326.20</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.314.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.326.20</div..." }, { "title": "Shilpa Medicare Ltd Hits Intraday High with 7.33% Surge on 9 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-hits-intraday-high-with-733-surge-on-9-feb-2026-3828494", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_priceRelatedfactors_3828494.png", "date": "2026-02-09 10:13:00", "description": "Shilpa Medicare Ltd recorded a robust intraday performance on 09 Feb 2026, surging to a day’s high of Rs 359.95, marking a significant 7.33% gain. The pharmaceutical and biotechnology company outpaced its sector and the broader market, reflecting heightened trading activity and volatility." }, { "title": "Shilpa Medicare Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3828129", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_gapup_3828129.png", "date": "2026-02-09 09:31:03", "description": "Shilpa Medicare Ltd commenced trading today with a significant gap up, opening 14.47% higher than its previous close, signalling robust positive sentiment in the Pharmaceuticals & Biotechnology sector. This strong start was accompanied by heightened volatility and outperformance relative to both its sector and the broader market indices." }, { "title": "Shilpa Medicare Ltd Reports Very Positive Quarterly Financial Performance Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-reports-very-positive-quarterly-financial-performance-amid-sector-challenges-3827719", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShilpaMedicareL_fintrenddot_3827719.png", "date": "2026-02-09 08:00:25", "description": "Shilpa Medicare Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, shifting its financial trend from positive to very positive. The pharmaceutical and biotechnology company recorded its highest quarterly net sales and profitability metrics in recent history, signalling a potential turnaround despite a challenging broader market environment." }, { "title": "Shilpa Medicare Gains 8.45%: 4 Key Factors Driving the Weekly Surge", "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-gains-845-4-key-factors-driving-the-weekly-surge-3826351", "imagepath": "", "date": "2026-02-07 15:06:55", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Stock opens lower at Rs.287.20 amid broader market weakness</p>\n <p><strong>3 Feb:</strong> Strong gap up opening, surging 7.94% intraday to Rs.310</p>\n <p><strong>6 Feb:</strong> Q3 FY26 results released; technical upgrade and rating change announced</p>\n <p><strong>6 Feb:</strong> Week closes at Rs.314.45, up 8.45% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.289.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div ..." }, { "title": "Are Shilpa Medicare Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-shilpa-medicare-ltd-latest-results-good-or-bad-3824852", "imagepath": "", "date": "2026-02-06 19:24:51", "description": "Shilpa Medicare Ltd's latest financial results for Q3 FY26 reflect a strong operational performance, with net sales reaching ₹409.73 crores, marking the highest quarterly figure in the company's history. This represents a year-on-year growth of 28.32% and a quarter-on-quarter increase of 10.75%. The net profit for the quarter stood at ₹44.58 crores, showing a year-on-year growth of 40.28% and a slight quarter-on-quarter increase of 1.16%. \n\nThe operating margin for Q3 FY26 was reported at 27.90%, which is the highest in eight quarters, indicating effective cost management despite a marginal decline from the previous quarter's 29.27%. However, the profit after tax margin of 10.88% has decreased from 11.91% in Q2 FY26, raising concerns about sustainability.\n\nDespite these positive operational metrics, the company continues to face challenges regarding capital efficiency, as indicated by a return on equity (RO..." } ], "total": 375, "sid": "780523", "stock_news_url": "https://www.marketsmojo.com/news/shilpa-medicare-780523" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement", "datetime": "05-Mar-2026", "details": "NCLT order on merger of Shilpa Therapeutics Private Limited a wholly owned subsidiary with Shilpa Media Limited.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "24-Feb-2026", "details": "Press release", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "19-Feb-2026", "details": "Newspaper advertisement - Special Window for Transfer and Dematerialisation of Physical shares.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has declared <strong>100%</strong> dividend, ex-date: 17 Sep 25", "dt": "2025-09-17", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has announced <strong>1:2</strong> stock split, ex-date: 06 Nov 15", "dt": "2015-11-06", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Shilpa Medicare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 03 Oct 25", "dt": "2025-10-03", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Feb 09: Intraday high surge to Rs.359.95 with a 14.47% gap up

Feb 09: Very positive quarterly financial results reported

Feb 11-12: Consecutive declines amid technical caution

Feb 13: Modest recovery to close the week at Rs.326.20

Week Open

Rs.314.45

Week Close

Rs.326.20Read full news article

Shilpa Medicare Ltd Hits Intraday High with 7.33% Surge on 9 Feb 2026

2026-02-09 10:13:00

Shilpa Medicare Ltd recorded a robust intraday performance on 09 Feb 2026, surging to a day’s high of Rs 359.95, marking a significant 7.33% gain. The pharmaceutical and biotechnology company outpaced its sector and the broader market, reflecting heightened trading activity and volatility.

Read full news article

Shilpa Medicare Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment

2026-02-09 09:31:03

Shilpa Medicare Ltd commenced trading today with a significant gap up, opening 14.47% higher than its previous close, signalling robust positive sentiment in the Pharmaceuticals & Biotechnology sector. This strong start was accompanied by heightened volatility and outperformance relative to both its sector and the broader market indices.

Read full news article

Shilpa Medicare Ltd Reports Very Positive Quarterly Financial Performance Amid Sector Challenges

2026-02-09 08:00:25

Shilpa Medicare Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, shifting its financial trend from positive to very positive. The pharmaceutical and biotechnology company recorded its highest quarterly net sales and profitability metrics in recent history, signalling a potential turnaround despite a challenging broader market environment.

Read full news article

Shilpa Medicare Gains 8.45%: 4 Key Factors Driving the Weekly Surge

2026-02-07 15:06:55

Key Events This Week

2 Feb: Stock opens lower at Rs.287.20 amid broader market weakness

3 Feb: Strong gap up opening, surging 7.94% intraday to Rs.310

6 Feb: Q3 FY26 results released; technical upgrade and rating change announced

6 Feb: Week closes at Rs.314.45, up 8.45% for the week

Week Open

Rs.289.95

Week Close

Read full news article

Are Shilpa Medicare Ltd latest results good or bad?

2026-02-06 19:24:51

Shilpa Medicare Ltd's latest financial results for Q3 FY26 reflect a strong operational performance, with net sales reaching ₹409.73 crores, marking the highest quarterly figure in the company's history. This represents a year-on-year growth of 28.32% and a quarter-on-quarter increase of 10.75%. The net profit for the quarter stood at ₹44.58 crores, showing a year-on-year growth of 40.28% and a slight quarter-on-quarter increase of 1.16%. The operating margin for Q3 FY26 was reported at 27.90%, which is the highest in eight quarters, indicating effective cost management despite a marginal decline from the previous quarter's 29.27%. However, the profit after tax margin of 10.88% has decreased from 11.91% in Q2 FY26, raising concerns about sustainability. Despite these positive operational metrics, the company continues to face challenges regarding capital efficiency, as indicated by a return on equity (RO...

Read full news article

View All News